chrisvoncsefalvay/vaers-outcomes huggingface dataset:
solid red rash; Arm pain; Arm itches; This is a spontaneous report from a contactable consumer or other non health care professional (patient). A 59-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ER8730) dose 2, via an unspecified route of administration, administered in arm left on 25Mar2021 at 05:45 PM (age at vaccination 59 years) as dose 2, single for COVID-19 immunization. Medical history included diabetes type 2, high blood pressure, high cholesterol, IBS-D (Irritable bowel syndrome with diarrhoea), low acting thyroid, anxiety and allergy to cats. The patient previously took sulfa, polysporin, erythromycin and experienced allergy, cephale and experienced rash. Concomitant medications included dapagliflozin propanediol monohydrate (FARXIGA) 5mg, Levothyroxine 100mcg, Lisinopril 10mg M. Covid prior vaccination and covid tested post vaccination was reported as no. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 and Since the vaccination, the patient has not been tested for COVID-19.The patient previously received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6206) via an unspecified route of administration, administered in arm left on 04Mar2021 06:15 PM (age at vaccination 59 years) as dose 1, single for COVID-19 immunization. On 27Mar2021, patient experienced arm pain was going away, arm itches and there was a solid red rash. Seriousness of the events were non serious. The patient did not receive any treatment for the adverse events however Calamine lotion helps. The outcome of all the events was not recovered.  No follow-up attempts are needed. No further information is expected.
1 week after shot after initial arm pain reaction was gone...arm swelling redness burning itching, headache and diarrhea
Starting about middle of my chest up to my neck it started to get little bit bubbles on it and now it's just burning like crazy and it's starting around my ankles; It's like my chest is burned; This is a spontaneous report from a contactable consumer (patient). A 79-year-old Female patient (also the age at vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261), via an unspecified route of administration on 29Jan2021 at SINGLE DOSE for COVID-19 immunization. Medical history included Atrial fibrillation (AFib) and back surgery (reported as: I am recovering from very serious back surgery) both from an unknown date and unknown if ongoing. Concomitant medication included methotrexate (reported as , it's a little cancer pill (Further clarification was unknown if consumer have cancer, hence cancer was not captured in medical condition), once a week), tocilizumab (ACTEMRA) (reported as I am on IV Infusions every 4 weeks and the name of it is Actemra), apixaban (ELIQUIS) (reported as I am on Eliquis because I am AFib, heart), and then another heart medicine plus all the patient's 'vitamins' (unspecified). The patient previously took oxycodone and experienced allergy (reported as I can't take any of those drugs, I am allergic to all that stuff. Yeah I can't take any of that pain medicine (Unspecified Medications)). The patient stated that: "I was calling about the, I had my first shot for the virus and on my chest, starting about middle of my chest up to my neck it started to get little bit bubbles on it and now it's just burning like crazy and it's starting around my ankles. Does that have anything to do with that shot?" The reporter confirmed that the next shot is due on 22Feb2021. The patient added that, "Actually last week they were really light, and they just keep getting worst. I was actually going to call my doctor tomorrow because I was concerned about getting this injection anyways because of my history on having reactions to medicine. I can't take any like Oxycodone or like any of those (also reported as "I can't take any of those drugs, I am allergic to all that stuff. Yeah I can't take any of that pain medicine (Unspecified Medications). No, I don't have anything like that."). I can't take any of those drugs (Unspecified Medications). And she said she thought it would be alright but I am recovering from very serious back surgery and so I have had a hard time with that. So, I thought I should call and see if I should get my second injection or if I should just let it go." It was also reported that:  "Yes, it's like my chest is burned." Consumer stated for the treatment, "The only thing I put on was Benadryl cream. To keep it from 'itching'." The patient asked "Should I get the second injection?" The outcome of the events was unknown.
About 5-6 hrs after DTaP pt had fever with seizure. He had had a febrile seizure the night before with diagnosis of ear infection.
Woke up at 1:30 a.m. shaking because cold, headache.  Later in the day had temp of 101.1 degrees for several hours.  I could not get warm despite 2 hot baths and house at 80 degrees.  Fatigue, rested in bed a lot.  Went to bed and woke up in 1 hour sweating. Woke up the next morning, today, and seem to be fine.  Not cold or hot, doing lots of household chores, etc.
hurt a bit in the same arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (hurt a bit in the same arm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ATORVASTATIN, LORAZEPAM (ATIVAN), HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ), LOSARTAN, AMLODIPINE, ASA, OMEPRAZOLE, LEVOTHYROXINE SODIUM (SYNTHROID) and TADALAFIL (CIALIS) for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (hurt a bit in the same arm). At the time of the report, PAIN IN EXTREMITY (hurt a bit in the same arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported .   This case was linked to MOD-2021-077869 (E2B Linked Report).; Sender's Comments:  MOD-2021-077869:First dose case
This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 7-year-old male patient who received FLUARIX QUADRIVALENT. On an unknown date, the patient received FLUARIX QUADRIVALENT 0.5 ml. On an unknown date, 1 day after receiving FLUARIX QUADRIVALENT, the patient experienced injection site rash and vomiting. On an unknown date, the outcome of the injection site rash and vomiting were recovered/resolved. It was unknown if the reporter considered the injection site rash and vomiting to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The exact date of the vaccination was unknown. The pharmacist believed it might have been Friday but she was not certain.
The Pentacel Diluent (DTaP./IPV) was mixed with the powder Rotavirus and given IM.  The Nurse realized her mistake after she returned to her work area.  The parent, Doctor and Nursing Team Leader was notified of the error.  The Nursing supervisor contacted and Sanofi Pasteur and learned that the patient could have a slight local reaction.  We instructed the Mother to let us know if child has any issues within the next 48 to 72 hours and if showing signs of an allergic reaction to go to the ER.
Starting 07/09/2022, I started feeling really exhausted and had difficulty getting up out of bed. It continued to worsen over the next few days. On Monday, I found myself in the worse pain I've had in forever and it was all over no matter what I did. I was unable to get comfortable and I had constant headaches. My eye sight was starting to become double and I was wheezing a lot. I took an at home test (07/11/2022) and it was positive. I called the doctors office to let them know what happened. They told me to keep the inhaler on hand in case and they prescribed me Lagevrio (anti-viral that would not interfere with my medications). I have been trying to get as much rest as possible but I have been working the last few days except today (07/13/2022) where I could not work (I work from home). Today, I have no energy, loss of appetite and am exhausted.
Right arm rash. Patient did get the flu vax and PNEUMOVAX in that arm on 10/13/09. Patient was given KEFLEX and told to use BENADRYL PRN.
pt recvd vax 10AUG93 & immed following vax felt faint, weak, nauseated, dizzy, cold & clammy & blacked out; pt cont to feel lightheaded & nauseated until later in the day when pt recovered; No further details were provided;
Reddened area approx. 3 in wide and 2 1/2 in long, warm to touch surrounding injection site of the left upper arm.
dizzy/vertigo / fatigue /mental fog feeling  / headache right sided all symptoms started post second vaccine approximately 2-14 days later , still persisting
5-6 hours after administration - Developed sore arm with erythema at site of injection developing over next several hours to cover upper 1/2 of front of upper arm with swelling to elbow.  Developed swelling of tongue with small blister type formation and upper respiratory congestion.  Mouth swelling resolved within 12 hours with respiratory congestion for 24 hours and upper arm developing mild cellulitus - Bendryl given over first 24 hours with antibiotic (Keflex) for arm - Missed 2 days of work
covid 19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (covid 19) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 06SK21A, 032F21A, 030L20A and 037K20A) for COVID-19 prophylaxis.     It was reported that patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concurrent medical conditions included Colitis, Hashimoto's disease, Autoimmune disorder and Chronic appendicitis (10 years ago).   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2022, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Aug-2022, SARS-CoV-2 test: Positive. On an unknown date, Antibody test: Inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had some immunocompromising issues. Patient has an undiagnosed autoimmune disorder, colitis, Hashimoto's and some other things in background that make immunocompromised.  Patient received influenza vaccine on 14 Oct 2022.  No Concomitant medications were provided.  On 14 Oct 2022 patient received bivalent booster with lot number reported as 051D22A. It was reported that patient wanted to ask about availability. Patient got fifth shot which was the bivalent on 14 Oct 2022.  Patient sees ads on TV and messages on phone that if its been more than 6 months patient should consider getting another booster.  Patient got COVID around 21 Aug 2022 from a visitor at house. She and her husband both tested positive.  Patient wanted to get the next shot but not sure if its the same shot that patient got in October. The insurance site says you should be boosted again. You should stick with what you started with - if you got Moderna, you should stick with Moderna.  Patient wonders if they mean getting different bivalent boosters.  Within the month of first two shots in early February patient got an antibody test recommended by physician. Patient didnt have any evidence of having antibodies from the first two vaccines. Patient will try to find out the date of the antibody test and call back. The patient read about people who are autoimmune and they are not having antibodies after having both COVID and flu vaccine.   No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Mar-2023: Live Significant follow-up received included updated medical history.
Woke up with a rash(hives) on her stomach.  Within hours in had spread to her entire body.  This caused severe itching and irratibility.
Data exchange not properly working in EHR. Office procedure did not include reconciliation of vaccines, causing extra dose to be given.
The first COVID vaccine the patient received was Moderna (on April 3rd).  The patient received it at his last base.  He then moved and presented to the military vaccination site for his second dose.  The site administered Pfizer.  Only after the patient had received the vaccine was the card presented to document the patient's shot, and the first Moderna vaccine given was noted.  The patient suffered no deleterious effects.
Pt developed positive evidence of calcified nodule on left thigh at injection site of DTAP.
Mom reports a small rash was present prior to the administration of the vaccines. Today, mom reports that the rash had spread from her trunk to her legs and face.
Face swelled up, swelling included eyes, nose, and upper lip. Itchiness in face.  Started with one eye swollen almost shut, with some itchiness. Then the next day while upper face was swelling and eyes were both swollen almost shut.
No adverse events noted, but yellow fever was given on 2/16/17, before the patient knew she was pregnant. LMP was 1/31/17.
Product was expired on 06 Jun 2023, and it was stored in refrigator on 07 Jun 2023; No adverse event; patient was administered Moderna Vaccine on 08 Jun 2023, which was expired vaccine was 06 Jun 2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered Moderna Vaccine on 08 Jun 2023, which was expired vaccine was 06 Jun 2023), PRODUCT STORAGE ERROR (Product was expired on 06 Jun 2023, and it was stored in refrigator on 07 Jun 2023) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 024H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 08-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered Moderna Vaccine on 08 Jun 2023, which was expired vaccine was 06 Jun 2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product was expired on 06 Jun 2023, and it was stored in refrigator on 07 Jun 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered Moderna Vaccine on 08 Jun 2023, which was expired vaccine was 06 Jun 2023), PRODUCT STORAGE ERROR (Product was expired on 06 Jun 2023, and it was stored in refrigator on 07 Jun 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient was administered Moderna Vaccine on 08 Jun 2023, which was expired vaccine was 06 Jun 2023) and PRODUCT STORAGE ERROR (Product was expired on 06 Jun 2023, and it was stored in refrigator on 07 Jun 2023).    The vial size was 2.5ml. The date the vial was initially stored in the refrigerator was 07 Jun 2023. The vial had not undergo any temperature excursions. Concomitant medications were not reported.  No treatment information was provided by the reporter. This case was for patient 3 out of 5.   This case was linked to US-MODERNATX, INC.-MOD-2023-728778 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-728778:Master case
Information has been received from a consumer concerning one of her cousins who was vaccinated with MMR II. After receiving the vaccine, the patient had loss of consciousness for a while. The consumer stated that most of her family members had this immune disorder that made them react to live vaccines that were given in combination with other live vaccines. Follow up has been received from the consumer who stated that her cousin "passed out and quit breathing" after getting MMR II. This is one of several reports received from the same source. Upon internal review "quit breathing" was determined to be an other important medical event. Additional information is not available.
Information has been received from a physician concerning a 21 year old female who on 05-SEP-2008 was vaccinated with a first dose of GARDASIL and on 14-NOV-2008 was vaccinated with a second dose of GARDASIL. Then the patient was diagnosed with transverse myelitis, which the physician stated it mimics multiple sclerosis. The patient saw a neurologist. At the time of reporting, the outcome was unknown. Upon internal review, transverse myelitis was determined to be an other important medical event. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. No information about medical history, drug reactions and allergies was specified. Pharmacist reported that a patient received a dose of ZOSTAVAX (lot # K000456, expiry date 15-DEC-2014, strength 19400 plaque-forming unit (PFU) dose, route not reported). The patient was not on any concomitant medications. The patient developed redness around the injection site, "shortly after" the administration on 29-JUL-2014. No lab diagnostics studies were performed. There was no product quality complaint. No treatment was given for the event. The patient sought medical attention at the pharmacy visit. The action taken with ZOSTAVAX is unknown. Pharmacist reports that the patient still has the redness around the injection but it is "getting better" (recovering). The causality of the event is unknown. Additional information has been requested.
After the vaccine there was sensitivity in my right thigh, and I wasn't feeling well. That same night I got a light red rash on my thigh and over the day the rash got worse , and on the third day I ended up with blisters all over my right thigh.
Varicella vaccine given March 10th 2005. March 28 morning, malaise. March 28 evening, 100 degree temperature. March 29 all day, joint aches but temperature is normal. March 30 afternoon, I feel fine but I have raised bumps that itch, mostly on chest and back. March 31 more bumps on head with a couple on face and arms. None of the red bumps break open but they do have a raised point in the center.... they itch a lot. April 1-2 I don't seem to see any new bumps but the ones I have still itch and a few have tiny little scabs.... like extremely mild chickenpox says my mom. Otherwise I have felt fine since March 30.
I had a 101 degree fever for 36 hours. About 10 days after my right ankle, left knee and right wrist developed swelling in the joints. They have been swollen ever since.
This case was reported by a physician and described the occurrence of bordetella pertussis in a subject of unspecified age and gender who was vaccinated with PEDIARIX (GlaxoSmithKline), INFANRIX. On an unspecified date the subject received unspecified dose of PEDIARIX (unknown) or an unspecified dose of INFANRIX (unknown). At an unspecified time after vaccination with INFANRIX or PEDIARIX, the subject experienced bordetella pertussis and bordetella pertussis test positive. The physician inquired about storage/transportation recommendations and reported a subject tested positive for Pertussis after being vaccinated with INFANRIX or PEDIARIX. The physician did not remember any details of the regarding the subject. At the time of the report no additional information was available. At the time of reporting the outcome of the Bordetella pertussis and Bordetella pertussis test positive was unspecified. The physician reported another case of Bordetella pertussis test positive, for that subject please see case A1024572A.
Extreme fatigue that prevents normal work day activities,  and life activities. I am always exhausted, in need of a nap and have to stop in order to take a nap that lasts from 30 minutes to 3 hours. As time has passed the length of napping has increased. I cannot make it through the day. I go to bed at night between 8:30 and 9:00 PM and still need naps. I have never been a napper and never liked napping but now it is what gets me through the day.
floaters in her left eye which are still there; very tired and run down that night; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (floaters in her left eye which are still there), FATIGUE (very tired and run down that night), PYREXIA (fever) and HEADACHE (headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced FATIGUE (very tired and run down that night), PYREXIA (fever) and HEADACHE (headache). On 01-May-2021, the patient experienced VITREOUS FLOATERS (floaters in her left eye which are still there). On 01-May-2021, FATIGUE (very tired and run down that night), PYREXIA (fever) and HEADACHE (headache) had resolved. At the time of the report, VITREOUS FLOATERS (floaters in her left eye which are still there) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-175972 (Patient Link).
A male patient received vaccine on 06/04/08 and on 06/08/08 patient went to ER, where he was diagnosed with cellulitis in the area of injection site.  Patient was given KELFEX antibiotics to treat the adverse reaction.  Follow up on 08/13/08: patient recovered.
Severe vagal response with convulsion-like activity immediately following vaccination with MENACTRA. 2 more vagal episodes followed over 10-15 minutes. Remained drowsy and very weak. Transported to ER via ambulance.
2 of 2 shots (1 of 2 shots administered in Oct 2019 with no ill side effects) Symptoms began 12 hours after dosage. Stomach pain with diarrhea/loose stool then nausea, headache, shivering all night with very cold hands/feet but did not feel feverish. Woke up after several hours of sleeping on my left side with left leg pain, feeling of swollen leg (but it was not swollen), sore joints/sore left hip. Slept for another 12 hours.  The next day I felt as though I was "beat up." Little appetite, very achy.  Injection site has been warm and sensitive to touch.    Note:  The pharmacy date of prescription is 2/20/2020 because I called to order the shot on 2/20, but I did not actually get the shot until Saturday, 2/22/2020.